Get started
Author

Peggy J. de Vos van Steenwijk

Observed names: P. J. de Vos van Steenwijk, P. J. de Vos van Steenwijk, P.J. De Vos van Steenwijk, P.J. Steenwijk, P.J. de Vos van Steenwijk, Peggy De Vos van Steenwijk, Peggy J De Vos Van Steenwijk, Peggy J de Vos van Steenwijk, Peggy J. De Vos Van Steenwijk, Peggy J. De Vos van Steenwijk, Peggy J. Vos, Peggy J. de Vos Van Steenwijk, Peggy JDe Vos-Van Steenwijk, Peggy de Vos van Steenwijk, Peggy de Vos-van Steenwijk, Steenwijk, P.J.D. van, Vos van Steenwijk, P.J. de, de Vos van Steenwijk, PJ
Observed institutions: Leiden University, Leiden University Medical Center, Maastricht University Medical Centre, Erasmus MC, Maastricht University, Academisch Ziekenhuis Rotterdam, Erasmus University Rotterdam
ORCID: 0000-0002-9822-9529
Observed ORCID: 0000-0002-9822-9529
OpenAlex ID: A5071492905
M2 Macrophages Induced by Prostaglandin E2 and IL-6 from Cervical Carcinoma Are Switched to Activated M1 Macrophages by CD4+ Th1 Cells
2011 · Moniek Heusinkveld, Peggy J de Vos van Steenwijk, et al. · The Journal of Immunology · 368
PDF
Success or failure of vaccination for HPV16-positive vulvar lesions correlates with kinetics and phenotype of induced T-cell responses
2010 · Marij J. P. Welters, Gemma G. Kenter, et al. · Proceedings of the National Academy of Sciences · 239
Prevention of Adhesion to Prosthetic Mesh
2003 · Martijne van ’t Riet, Peggy J. de Vos van Steenwijk, et al. · Annals of Surgery · 200
Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes
2020 · Kim E. Kortekaas, Esther Bastiaannet, et al. · Gynecologic Oncology · 137
PDF
Tumor‐infiltrating CD14‐positive myeloid cells and CD8‐positive T‐cells prolong survival in patients with cervical carcinoma
2013 · P.J. de Vos van Steenwijk, T.H. Ramwadhdoebe, et al. · International Journal of Cancer · 129
PDF
Tensile strength of mesh fixation methods in laparoscopic incisional hernia repair
2002 · M. Riet, P.J. Steenwijk, et al. · Surgical Endoscopy · 127
A placebo-controlled randomized HPV16 synthetic long-peptide vaccination study in women with high-grade cervical squamous intraepithelial lesions
2012 · Peggy J. de Vos van Steenwijk, Tamara H. Ramwadhdoebe, et al. · Cancer Immunology Immunotherapy · 93
PDF
Mesh repair for postoperative wound dehiscence in the presence of infection: is absorbable mesh safer than non-absorbable mesh?
2007 · M. van’t Riet, P. J. de Vos van Steenwijk, et al. · Hernia · 88
An Unexpectedly Large Polyclonal Repertoire of HPV-Specific T Cells Is Poised for Action in Patients with Cervical Cancer
2010 · Peggy J. de Vos van Steenwijk, Moniek Heusinkveld, et al. · Cancer Research · 84
PDF
Incisional Hernia after Repair of Wound Dehiscence: Incidence and Risk Factors
2004 · Martijne Van ‘T Riet, Peggy J. De Vos Van Steenwijk, et al. · The American Surgeon · 70
The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study
2013 · Peggy J. de Vos van Steenwijk, Mariette I. E. van Poelgeest, et al. · Cancer Immunology Immunotherapy · 68
The Anatomical Location Shapes the Immune Infiltrate in Tumors of Same Etiology and Affects Survival
2018 · Saskia J. Santegoets, Vanessa J. van Ham, et al. · Clinical Cancer Research · 58
How the Gut Microbiome Links to Menopause and Obesity, with Possible Implications for Endometrial Cancer Development
2021 · Malou P. H. Schreurs, Peggy J. de Vos van Steenwijk, et al. · Journal of Clinical Medicine · 55
PDF
Surgery followed by Persistence of High-Grade Squamous Intraepithelial Lesions Is Associated with the Induction of a Dysfunctional HPV16-Specific T-Cell Response
2008 · Peggy J. de Vos van Steenwijk, Sytse J. Piersma, et al. · Clinical Cancer Research · 42
Intradermal vaccination of HPV-16 E6 synthetic peptides conjugated to an optimized Toll-like receptor 2 ligand shows safety and potent T cell immunogenicity in patients with HPV-16 positive (pre-)malignant lesions
2022 · Frank M Speetjens, Marij J P Welters, et al. · Journal for ImmunoTherapy of Cancer · 39
PDF
Pre-existing inflammatory immune microenvironment predicts the clinical response of vulvar high-grade squamous intraepithelial lesions to therapeutic HPV16 vaccination
2020 · Ziena Abdulrahman, Noel de Miranda, et al. · Journal for ImmunoTherapy of Cancer · 36
PDF
Immunologic factors involved in the malignant transformation of endometriosis to endometriosis-associated ovarian carcinoma
2021 · S. Leenen, M. Hermens, et al. · Cancer Immunology Immunotherapy · 31
Vaginal Microbiota and Local Immunity in HPV-Induced High-Grade Cervical Dysplasia: A Narrative Review
2025 · Helena C. J. Schellekens, Lotte M. S. Schmidt, et al. · International Journal of Molecular Sciences · 30
Topical Imiquimod Treatment of High-grade Cervical Intraepithelial Neoplasia (TOPIC-3): A Nonrandomized Multicenter Study
2022 · Natasja Hendriks, Margot M. Koeneman, et al. · Journal of Immunotherapy · 30
Importance of the Immune Microenvironment in the Spontaneous Regression of Cervical Squamous Intraepithelial Lesions (cSIL) and Implications for Immunotherapy
2022 · Caroline L. P. Muntinga, Peggy J. de Vos van Steenwijk, et al. · Journal of Clinical Medicine · 27
PDF
The immune microenvironment in vulvar (pre)cancer: review of literature and implications for immunotherapy
2018 · Ziena Abdulrahman, Kim E Kortekaas, et al. · Expert Opinion on Biological Therapy · 24
The efficacy of topical imiquimod in high‐grade cervical intraepithelial neoplasia: A systematic review and meta‐analysis
2023 · A. J. M. van de Sande, M. Kengsakul, et al. · International Journal of Gynecology & Obstetrics · 19
PDF
A pre‐existing coordinated inflammatory microenvironment is associated with complete response of vulvar high‐grade squamous intraepithelial lesions to different forms of immunotherapy
2020 · Ziena Abdulrahman, Noel F. C. C. de Miranda, et al. · International Journal of Cancer · 17
PDF
Immune-based biomarker accurately predicts response to imiquimod immunotherapy in cervical high-grade squamous intraepithelial lesions
2022 · Ziena Abdulrahman, Natasja Hendriks, et al. · Journal for ImmunoTherapy of Cancer · 15
PDF
Optimising follow-up strategy based on cytology and human papillomavirus after fertility-sparing surgery for early stage cervical cancer: a nationwide, population-based, retrospective cohort study
2023 · Teska N Schuurman, Mirte Schaafsma, et al. · The Lancet Oncology · 14
PDF
Works count: 68
Citation count: 2,067
H-index: 21
I10-index: 25
Year
Topic
Type